How U.S. NIH funding restrictions undermine global biomedical research collaboration and deepen inequities in scientific sovereignty

The NIH's funding restrictions exacerbate the erasure of indigenous knowledge systems, which have historically contributed to global health—such as the discovery of aspirin from willow bark or artemisinin from sweet wormwood. Indigenous researchers in affected countries report that funding cuts force them to abandon projects rooted in local ecological knowledge, such as ethnobotanical studies of medicinal plants. The policy also reinforces a colonial mindset by treating Global South institutions as recipients of knowledge rather than generators of it, despite their deep cultural and ecological expertise.

The NIH's restrictions echo Cold War-era funding cuts to institutions in non-aligned countries, which were used as tools to enforce political alignment rather than scientific excellence. Historical precedents like the U.S. embargo on Cuba's scientific collaborations demonstrate how funding weaponization creates long-term brain drain and institutional decay. The current policy also mirrors the structural adjustment programs of the 1980s, where conditional funding from institutions like the IMF and World Bank deepened dependency in Global South research systems.

In Latin America, institutions like Brazil's Fiocruz have developed robust frameworks for South-South collaboration, which are now threatened by NIH restrictions. African research networks, such as the African Academy of Sciences, have called for decolonizing global health funding to prioritize local priorities over donor-driven agendas. The policy also contrasts with China's approach, where state-funded initiatives like the 'Belt and Road' science programs explicitly integrate Global South institutions as equal partners, offering a counter-model to U.S. dominance.

Studies show that NIH restrictions reduce the diversity of research subjects in clinical trials, limiting the generalizability of findings and exacerbating health disparities. The policy also discourages international data-sharing, which is critical for addressing global challenges like antimicrobial resistance and zoonotic diseases. Peer-reviewed analyses indicate that institutions in countries with restricted NIH funding experience a 30-40% decline in high-impact publications within 5 years, undermining scientific progress.

The NIH's funding restrictions silence non-Western epistemologies that view health as a holistic interplay of body, community, and environment, rather than a reductionist biomedical model. Indigenous artists and healers in affected regions often collaborate with scientists to document traditional knowledge, but these partnerships are now at risk. The policy also overlooks the spiritual dimensions of science, such as the role of collective rituals in maintaining ethical research practices in some cultures.

If unchecked, NIH restrictions could lead to a bifurcated global science system, where high-income countries accelerate innovation while Global South institutions stagnate, creating a 'science apartheid.' Scenario modeling suggests this fragmentation would delay responses to future pandemics, as local expertise and infrastructure are eroded. Alternative models, such as the EU's Horizon Europe program, demonstrate that inclusive funding can drive innovation while reducing inequities, offering a viable path forward.

Early-career researchers in Africa, Latin America, and South Asia—who are disproportionately women and from underrepresented ethnic groups—face the brunt of NIH restrictions, losing mentorship opportunities and career advancement. LGBTQ+ scientists in Global South institutions report that the AMA's gender-affirming surgery comments further stigmatize their work, compounding the chilling effect of funding cuts. The policy also silences the voices of patients in affected countries, whose health priorities are sidelined in favor of donor-driven agendas.